Hematological disorders

View All

Delveinsight
Global atrial fibrillation market is expected to grow to $12.5 billion by 2020

Global AF market was $7.2 billion in 2015 and expected to grow to $12.5 billion by 2020 with and compound annual growth rate (CAGR) of 11.62%. There are four NOACs which are indicated for the treatment of AF such as Xarelto, Eliquis, Pradaxa and Savaysa. DelveInsight Atrial Fibrillation-Market Insights & Drugs ...

Find More

Delveinsight
Global VTE market is expected to grow to $4.75 billion by 2020

Venous Thromboembolism- Market Insights & Drugs Sales Forecast (VTE) -2020: New Report by DelveInsight suggests that the Global VTE market was $4.2 billion in 2015 and expected to grow to $4.75 billion by 2020 with a compound annual growth rate (CAGR) of 2.44%. DelveInsight Report “Venous Thromboembolism-Market ...

Find More

Delveinsight
DelveInsight’s Gene Therapy Reports: Launched

Immense Growth Potential in the Gene Therapy Market! DelveInsight has launched its Gene Therapy Report: “Gene Therapy Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape”. These Reports are the outcome of very best analytical abilities and diligent market research amalgamated with opin...

Find More

Delveinsight
Gene Therapy’s Emergence: The “New” approach for Huntington’s disease

Many companies have tried over the years to find a way to reverse the course of crippling neurodegenerative disorders like Huntington’s but have failed. Fortunately, Gene therapy has proven to be an answer to a wide range of serious neurodegenerative disorders like Huntington’s, and Parkinson’s etc. The HD gene vs...

Find More

Delveinsight
Are you ready to embrace Gene Therapy?

Gene Therapy: The “Big Value” Market! Gene therapy has been under scientific research for over 2 decades, but viable therapies have yet to gain commercial acceptance due to safety and delivery-related issues. However, Pfizer’s move and some other recent developments in the industry suggest that the therapy may be ...

Find More

Delveinsight
DelveInsight’s Hematological disorders based Gene Therapy Reports

Gene Therapy to “target” Hematological disorders! About Hematological disorders Hematology is the study of blood in health and disease. It includes problems with the red blood cells, white blood cells, platelets, blood vessels, bone marrow, lymph nodes, spleen, and the proteins involved in bleeding and clotting (h...

Find More

Delveinsight
Break the Gene Therapy Barrier with DelveInsight’s Gene Therapy Reports

Gene Therapy: The Future is here! Scientific research and clinical trials aren’t glamorous, but they are essential for effective treatments and perhaps ultimately a cure for various debilitating diseases like cancer etc. Gene therapy's potential to revolutionize medicine in the future is exciting, and one day it m...

Find More

Delveinsight
Gene Therapy Market

Drive your Research towards a Brighter Future with DelveInsight! What do you feel when you see, cancer is getting cured by replacing the faulty or missing gene with the functional gene so that they can produce a protein to repair the anomaly responsible for the disease. Awesome Innovation Right! Delve...

Find More